Perrigo

US-based drugs giant plans to reconfigure its share capital to create a distributable reserve

Drug company not being ‘singled out’ in dispute over tax assessment, High Court told

Tax collector maintains Perrigo owes the money because of its 2013 purchase of Elan

Pharma group challenging ‘surprise’ Revenue assessment in hearing via video link

US drug company case to be heard via video link due to Covid-19 courtroom restrictions

Irish tax authorities argue sale of drug for MS should have been treated as capital gain

Salesforce, Glanbia and CRH to report; Guaranteed Irish roadshow on future trends takes place in UCC

US analyst RBC upbeat about High Court challenge to €1.64bn charge over Tysabri

Darina Allen talks to women who don’t lunch, while the FT’s Martin Wolf talks transformation

Edmund Burke Institute says Ireland’s reputation for tax certainty is being undermined

CSO figures to give clearer insight into state of affairs for Irish car industry; Glanbia and Kerry Group to report

Rulings in most cases unlikely this year as Tax Appeals Commission tackles backlog

Tax bill linked to sale by Elan of its stake in multiple sclerosis drug Tysabri in 2013

Perrigo has repeatedly argued it will defend its position in the tax case, and denies Elan underpaid tax on the Tysabri deal

Revenue should not have issued notice of amended assessment of liability, firm says

This Week: Big week for banks as SME lending stays weak amid Brexit caution

Theratechnologies has appointed Conor Walshe to the role of general manager

Drugmaker’s CEO says it’s hard to run a business with a complex portfolio from US

Pharma group understood to have filed documents to contest assessment

Listed pharmaceutical giant has signalled its intention to appeal Revenue’s tax assessment

Seen & Heard: Average pay at Goodbody stockbrokers reached €138,000 last year

Cliff Taylor: Contrasting approaches to tax bills show the delicate balance Ireland must strike

Company confirmed it faces Revenue demand for €1.64bn in back taxes

Revenue’s activist approach has not gone unnoticed

Money would cover the full cost of the National Children’s Hospital

Cliff Taylor answers all your questions

Claim relates to a row over the amount of tax paid on the sale of a stake in a major drug

Figures from Cushman & Wakefield show more than €505m invested in third quarter

At 47,500sq ft, top-end office block at Hogan Place will show 4.4 per cent yield

US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma

Dublin-domiciled company announces separation of prescription arm following review

New €20m six-storey block in Dublin 2 has parking for 40 cars and 56 bicycle spaces

Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013

Dublin-based drugmaker was urged last year to explore a sale of its prescription business

CEO John Hendrickson says drug faces increased competition and potential for wider use has failed to materialise

Purchaser of one-third of Treasury Building will get annual rent of €1.83m

Over-the-counter drug company buys US healthcare distributor for undisclosed sum

Company sales have halved since the company rejected Mylan takeover offer late last year

Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda

What Papa brings to the party is a depth of experience from over 30 years in the business